한글목차

보디 컨투어링 디바이스 시장 규모는 예측 기간 중 CAGR 11.4%로 확대하며, 2024년 17억 4,000만 달러에서 2029년에는 30억 달러에 달할 것으로 예측됩니다.

시장의 확대는 비침습적 보디 컨투어링 디바이스의 이용 확대, 소셜미디어를 통한 미용 시술 광고 증가, 이러한 시술을 위해 쉽게 접근할 수 있는 클리닉 및 미용 센터 등의 요인에 의해 촉진될 것입니다. 반면, 주요 업체들 간의 상당한 시장 통합과 막대한 자본 투자의 필요성은 시장 성장에 걸림돌로 작용하고 있습니다.

제품별로 시장은 주로 비침습과 침습으로 구분됩니다. 비침습적 부문은 2023년 보디 컨투어링 디바이스 중 가장 높은 성장률을 기록했습니다. 시장 성장의 큰 폭 증가는 주로 비침습적 및 저침습적 보디 컨투어링 디바이스의 광범위한 사용으로 인해 발생했습니다. 또한 지방 감소 및 바디 타이트닝 장비와 같은 응용 기술의 발전과 미용 성형 수술에 대한 수요 증가가 이 분야의 확장을 촉진하고 있습니다.

용도별로 시장은 주로 보디 토닝 및 조각, 지방 감소, 셀룰라이트 치료, 피부 타이트닝으로 구분되며, 2023년에는 비로봇 수술이 이 시장에서 가장 높은 점유율을 차지했습니다. 시장 성장을 이끄는 주요 요인은 지방 감소를 위한 비용 효율적인 시술, 위험 증가가 적은 중장년층을 제공하는 고주파 및 레이저와 같은 기술의 사용 증가입니다. 또한 외과 의사가 느린 체중 감량 과정보다 지방 감소 장비를 선호하는 것은 시장의 지속적인 번영에 기여하고 있습니다.

연령대별로는 35-50세, 50세 이상, 35세 이하로 구분되며, 2023년 보디 컨투어링 시장에서 가장 높은 성장률을 보인 연령대는 30-50세였습니다. 이 시장 성장의 주요 촉진요인은 중장년층의 비만 인구 증가, 이 연령대의 미적 외모를 위한 경쟁 증가, 소셜미디어에서 보디 컨투어링 시술에 대한 광고가 증가했기 때문입니다.

세계의 보디 컨투어링 디바이스 시장에 대해 조사했으며, 제품별, 용도별, 연령층별, 성별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 가격 분석
• 특허 분석
• 밸류체인 분석
• 공급망 분석
• 무역 분석
• 에코시스템 분석
• Porter's Five Forces 분석
• 규제 상황
• 기술 분석
• 2024-2025년 주요 컨퍼런스와 이벤트
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 주요 이해관계자와 구입 기준
• 투자와 자금조달 시나리오
• 보디 컨투어링 디바이스 시장에서 AI의 영향

제6장 보디 컨투어링 디바이스 시장(유형별)

• 서론
• 비침습성 디바이스
• 침습적 디바이스

제7장 보디 컨투어링 디바이스 시장(용도별)

• 서론
• 지방 감소
• 피부 타이트닝
• 보디 토닝 & 스컬프팅
• 셀룰라이트 치료

제8장 보디 컨투어링 디바이스 시장(연령층별)

• 서론
• 35세-50세
• 50세 이상
• 35세 미만

제9장 보디 컨투어링 디바이스 시장(성별)

• 서론
• 여성
• 남성

제10장 보디 컨투어링 디바이스 시장(최종사용자별)

• 서론
• 전문 클리닉
• 메디컬 스파 & 뷰티 센터
• 병원

제11장 보디 컨투어링 디바이스 시장(지역별)

• 서론
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카
• GCC 국가

제12장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/비책
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제13장 기업 개요

• 주요 참여 기업
  • ABBVIE, INC.
  • INMODE LTD.
  • BAUSCH HEALTH COMPANIES INC.
  • CYNOSURE LUTRONIC
  • CUTERA, INC.
  • VENUS CONCEPT
  • ENDYMED MEDICAL
  • LUMENIS BE LTD.
  • ALMA LASERS
  • CANDELA CORPORATION
• 기타 기업
  • BTL AESTHETICS LTD.
  • MICROAIRE SURGICAL INSTRUMENTS, LLC
  • FOTONA
  • NOUVAG AG
  • ERCHONIA CORPORATION
  • KONMISON
  • SKINNOVATION PVT. LTD.
  • 3D AESTHETICS
  • ZIMMER MEDIZINSYSTEME GMBH
  • ROHRER AESTHETICS
  • SKIN AESTHETICS
  • SHARPLIGHT TECHNOLOGIES INC.
  • SEBBIN
  • DEKA M.E.L.A. S.R.L.
  • INDIBA

제14장 부록

영문목차

The body contouring devices market is projected to reach USD 3.00 Billion by 2029 from USD 1.74 Billion in 2024, at a CAGR of 11.4% during the forecast period. Market expansion is propelled by factors such as the growing utilization of non-invasive body contouring devices, increase in the advertisement of aesthetic procedures on social media and easily accessible clinics andbeauty centers for these procedures. Conversely, significant market consolidation among key players and the need for substantial capital investments pose notable obstacles to market growth.

"Non-invasive segment accounted for the highest CAGR."

By product, the market is primarily segmented into non-invasive and invasive. The non-invasive segment accounted for the highest growth rate of the body contouring devices in 2023. The substantial increase in market growth can be primarily attributed to the extensive utilization of both non-invasive and minimally invasive body contouring devices. Furthermore, advancements in the technology of application such as fat reduction and body tonning instruments and the growing demand for aesthetic and plastic surgeries are driving the expansion of this sector.

"The fat reduction segment accounted for the market share in the body contouring devices market, byapplication, during the forecast period."

Byapplication, the market is primarily segmented into body toning and sculpting, fat reduction, cellulite treatment and skin tighteing. In 2023, non-robotic surgery accounted for the highest share of this market. The main factors propelling the growth of the market are the cost effective procedures for fat reduction, increase use of technologies like radiofrequency and lasers that provides least risk risingmiddle aged population. Additionally, surgeons preference of fat reduction devices over the slow weight loss process, contributing to their continued prominence in the market.

"Between 35 to 50 years segment accounted for the highest growth rate."

By age group , the market is primarily segmented into between 35to 50 years, above 50 years and below 35 years . The between 30 to 50 years segment accounted for the highest growth rate of the body contouring devices age group market in 2023. The primary drivers of growth in this market are increase in obese population among the middle age population, increase competition among this age group population to look aesthetic and increase in advertisement of the body contouring procedures over social media.

"Female segment accounted for the largest market share."

By gender , the market is primarily segmented into female and male . The female segment accounted for the highest share of the body contouring devices gender market in 2023. Easy accessibility of the body contouring devices and procedures, increased adoption of the body changes by female for aesthetic appearance and improved technologically advanced procedures with lowest downtime are the major reasons attributing to the largest share of the gender body contouring devices market.

"Specialty clinics segment accounted for the highest share."

By end user, the market is primarily segmented into hospitals, specialty clinics and medical spas and beauty centers. The specialty clinics segment accounted for a larger share of the body contouring devices market in 2023. This can be credited to the significant volume of non-invasive surgical procedures carried out inspecialty clinics, facilitated by the presence of highly skilled healthcare professionals.

"Asia Pacific: The fastest-growing region in body contouring devices market."

The global body contouring devices market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. Various factors are contributing to the growth of the market in the Asia-Pacific (APAC) region, including escalating healthcare expenditure, increase in medical tourism in the regions like China, India, Vietnam, rising per capita income, expansion of private-sector healthcare facilities into rural areas across several APAC nations and the existence of high-growth markets in the region. Moreover, the advantageous regulatory landscape and low costs in this region are anticipated to further drive market expansion.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (31%), Asia- Pacific (20%), Latin America (4%), Middle East & Africa(2%) and GCC Countries (1%)

Lists of Companies Profiled in the Report:

• Abbvie, Inc. (US)
• Cutera (US)
• Bausch Health Companies Inc. (Canada)
• InMode Ltd. (Israel)
• Venus Concept (Canada)
• ENDYMED Medical (US)
• Cynosure Lutronic (US)
• Lumenis BE Ltd. (Israel)
• Alma Lasers (Israel)
• Candela Corporation (US)
• BTL Aesthetics Ltd. (UK)
• MicroAire Surgical Instruments LLC (US)
• Fotona (Slovenia)
• Nouvag AG (Switzerland)
• Erchonia Corporation (US)
• Konmison (China)
• Skinnovation Pvt. Ltd. (India)
• 3D Aesthetics (UK)
• Zimmer MedizinSystems Gmbh (Germany)
• Rohrer Aesthetics (US)
• Skin Aesthetics (India)
• SharpLight Technologies Inc. (Israel)
• Sebbin (France)
• Deka M.E.L.A. S.R.L. (Italy)
• INDIBA (Spain)

Research Coverage

This research report categorizes the body contouring devices market by product, application, age group, gender, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the body contouring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview; key strategies; product launch, approval, acquisition, merger and recent developments associated with the body contouring devices market. Competitive analysis of upcoming startups in the body contouring devices market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body contouring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (Growing adoption of minimally invasive and noninvasive aesthetic procedures), restraints (High cost of treatment and lack of reimbursement), opportunities (Improving healthcare infrastructure in emerging markets), and challenges (Stringent regulatory compliance and safety standards) influencing the growth of the body contouring devices market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body contouring devices market
• Market Development: Comprehensive information about lucrative markets - the report analyses the body contouring devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Abbvie, Inc. (US), Cutera (US), Bausch Health Companies Inc. (Canada), InMode Ltd. (Israel), Venus Concept (Canada) among others in body contouring devices market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 BODY CONTOURING DEVICES MARKET
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 ASSUMPTIONS & LIMITATIONS
  • 2.5.1 GROWTH RATE ASSUMPTIONS
  • 2.5.2 LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BODY CONTOURING DEVICES MARKET OVERVIEW
• 4.2 BODY CONTOURING DEVICES MARKET SHARE, BY TYPE, 2024 VS. 2029
• 4.3 BODY CONTOURING DEVICES MARKET SHARE, BY APPLICATION, 2024 VS. 2029
• 4.4 BODY CONTOURING DEVICES MARKET SHARE, BY AGE GROUP, 2024 VS. 2029
• 4.5 BODY CONTOURING DEVICES MARKET SHARE, BY GENDER, 2024 VS. 2029
• 4.6 BODY CONTOURING DEVICES MARKET SHARE, BY END USER, 2024 VS. 2029
• 4.7 BODY CONTOURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing adoption of minimally invasive and non-invasive aesthetic procedures
    • 5.2.1.2 Increasing awareness and acceptance of body contouring
    • 5.2.1.3 Increasing demand for aesthetic treatments among men
    • 5.2.1.4 Technological advancements
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of treatment and lack of reimbursement
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Improving healthcare infrastructure in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stringent regulatory compliance and safety standards
    • 5.2.4.2 Social and cultural barriers in emerging economies
• 5.3 PRICING ANALYSIS
  • 5.3.1 INDICATIVE PRICING MODEL ANALYSIS OF MARKET PLAYERS
  • 5.3.2 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION
• 5.4 PATENT ANALYSIS
  • 5.4.1 LIST OF MAJOR PATENTS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE ANALYSIS FOR LASER AESTHETIC DEVICES
• 5.8 ECOSYSTEM ANALYSIS
  • 5.8.1 BODY CONTOURING DEVICES MARKET: ROLE IN ECOSYSTEM
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 THREAT OF NEW ENTRANTS
  • 5.9.2 THREAT OF SUBSTITUTES
  • 5.9.3 BARGAINING POWER OF BUYERS
  • 5.9.4 BARGAINING POWER OF SUPPLIERS
  • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 REGULATORY ANALYSIS
    • 5.10.2.1 North America
      • 5.10.2.1.1 US
      • 5.10.2.1.2 Canada
    • 5.10.2.2 Europe
    • 5.10.2.3 Asia Pacific
      • 5.10.2.3.1 China
      • 5.10.2.3.2 Japan
      • 5.10.2.3.3 India
    • 5.10.2.4 Latin America
      • 5.10.2.4.1 Brazil
      • 5.10.2.4.2 Mexico
    • 5.10.2.5 Middle East
• 5.11 TECHNOLOGY ANALYSIS
  • 5.11.1 KEY TECHNOLOGIES
    • 5.11.1.1 Cryolipolysis
    • 5.11.1.2 Radiofrequency (RF)
    • 5.11.1.3 High-intensity-focused Ultrasound (HIFU)
  • 5.11.2 COMPLEMENTARY TECHNOLOGIES
    • 5.11.2.1 Laser-assisted devices
    • 5.11.2.2 Implants
  • 5.11.3 ADJACENT TECHNOLOGIES
    • 5.11.3.1 Body sculpting rollers
    • 5.11.3.2 Electrostimulation devices
• 5.12 KEY CONFERENCES & EVENTS IN 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.13.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 IMPACT OF AI ON BODY CONTOURING DEVICES MARKET

6 BODY CONTOURING DEVICES MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 NON-INVASIVE DEVICES
  • 6.2.1 RADIOFREQUENCY (RF) DEVICES
    • 6.2.1.1 Ability to deliver noticeable results with minimal downtime to drive market growth
  • 6.2.2 CRYOLIPOLYSIS/FAT FREEZING DEVICES
    • 6.2.2.1 Risk associated with fat freezing to challenge market growth
  • 6.2.3 HIGH-INTENSITY-FOCUSED ULTRASOUND (HIFU) DEVICES
    • 6.2.3.1 Minimal downtime of HIFU devices to support adoption
  • 6.2.4 LOW-LEVEL LASER THERAPY (LLLT) DEVICES
    • 6.2.4.1 Increased patient safety and quick results to support market growth
  • 6.2.5 OTHER NON-INVASIVE DEVICES
• 6.3 INVASIVE DEVICES
  • 6.3.1 LIPOSUCTION DEVICES
    • 6.3.1.1 Increasing obese population to drive growth
  • 6.3.2 LASER-ASSISTED DEVICES
    • 6.3.2.1 Shift towards minimally invasive aesthetic treatments to drive growth
  • 6.3.3 IMPLANTS/FILLERS
    • 6.3.3.1 Rising demand for cosmetic implants to fuel growth

7 BODY CONTOURING DEVICES MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 FAT REDUCTION
  • 7.2.1 INCREASING NUMBER OF NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES TO PROPEL MARKET GROWTH
• 7.3 SKIN TIGHTENING
  • 7.3.1 INTRODUCTION OF CUTTING-EDGE DEVICES TO FUEL UPTAKE
• 7.4 BODY TONING & SCULPTING
  • 7.4.1 INCREASED CONSUMER DESIRE FOR ENHANCED BODY AESTHETICS TO DRIVE MARKET GROWTH
• 7.5 CELLULITE TREATMENT
  • 7.5.1 ADVANTAGES ASSOCIATED WITH ROBOTIC-ASSISTED SURGERY TO BOOST MARKET GROWTH

8 BODY CONTOURING DEVICES MARKET, BY AGE GROUP

• 8.1 INTRODUCTION
• 8.2 BETWEEN 35 TO 50 YEARS
  • 8.2.1 GROWING INTEREST IN MAINTAINING YOUTHFUL APPEARANCE TO DRIVE MARKET GROWTH
• 8.3 ABOVE 50 YEARS
  • 8.3.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN ACCEPTANCE OF COSMETIC PROCEDURES TO BOOST MARKET
• 8.4 BELOW 35 YEARS
  • 8.4.1 INCREASING NUMBER OF CUSTOMIZABLE TREATMENT PLANS TO FAVOR MARKET GROWTH

9 BODY CONTOURING DEVICES MARKET, BY GENDER

• 9.1 INTRODUCTION
• 9.2 WOMEN
  • 9.2.1 INCREASED AWARENESS AND ACCESSIBILITY OF BODY CONTOURING PROCEDURES TO DRIVE MARKET GROWTH
• 9.3 MEN
  • 9.3.1 INCREASING ACCEPTANCE OF AESTHETIC PROCEDURES AMONG MEN TO BOOST UPTAKE

10 BODY CONTOURING DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 SPECIALTY CLINICS
  • 10.2.1 OPERATIONAL ENHANCEMENTS, COMBINED WITH TARGETED MARKETING STRATEGIES, TO PROPEL MARKET
• 10.3 MEDICAL SPAS & BEAUTY CENTERS
  • 10.3.1 AVAILABILITY OF MEDICAL TREATMENT IN COMFORTABLE AND RELAXING SETTINGS TO AID MARKET GROWTH
• 10.4 HOSPITALS
  • 10.4.1 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES IN HOSPITALS TO SUPPORT MARKET GROWTH

11 BODY CONTOURING DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Increased demand for aesthetic procedures to drive market growth
  • 11.2.3 CANADA
    • 11.2.3.1 Rapid increase in geriatric population and increased awareness about non-invasive body contouring procedures to boost market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Rising disposable incomes to boost use of body contouring devices
  • 11.3.3 UK
    • 11.3.3.1 Reduced stigma for body contouring procedures to drive market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Improved standard of living and growing disposable income to support market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing number of plastic surgeons to favor market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing demand for cosmetic procedures and rising availability of safe minimally invasive technology to fuel growth
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Growing availability of body contouring surgery to drive market
  • 11.4.3 JAPAN
    • 11.4.3.1 Increasing number of plastic surgeons to propel market growth in Japan
  • 11.4.4 INDIA
    • 11.4.4.1 Increasing disposable incomes to drive market growth in India
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Growing focus on medical tourism to drive market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing volume of surgical procedures to aid market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 IMPLEMENTATION OF FAVORABLE INITIATIVES TO BOOST MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGHER DISPOSABLE INCOMES TO SUPPORT MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BODY CONTOURING DEVICES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 LIST OF EVALUATED VENDORS
  • 12.5.2 STARS
  • 12.5.3 EMERGING LEADERS
  • 12.5.4 PERVASIVE PLAYERS
  • 12.5.5 PARTICIPANTS
  • 12.5.6 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.6.1 Company footprint
    • 12.5.6.2 Type footprint
    • 12.5.6.3 Application footprint
    • 12.5.6.4 Region footprint
• 12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
  • 12.8.1 ABBVIE, INC.
  • 12.8.2 CYNOSURE LUTRONIC
  • 12.8.3 CUTERA
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 ABBVIE, INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches & approvals
      • 13.1.1.3.2 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 INMODE LTD.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 MnM view
      • 13.1.2.3.1 Right to win
      • 13.1.2.3.2 Strategic choices
      • 13.1.2.3.3 Weaknesses & competitive threats
  • 13.1.3 BAUSCH HEALTH COMPANIES INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product approvals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 CYNOSURE LUTRONIC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Right to win
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses & competitive threats
  • 13.1.5 CUTERA, INC.
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 VENUS CONCEPT
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches & approvals
  • 13.1.7 ENDYMED MEDICAL
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
  • 13.1.8 LUMENIS BE LTD.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 ALMA LASERS
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 CANDELA CORPORATION
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches
• 13.2 OTHER PLAYERS
  • 13.2.1 BTL AESTHETICS LTD.
  • 13.2.2 MICROAIRE SURGICAL INSTRUMENTS, LLC
  • 13.2.3 FOTONA
  • 13.2.4 NOUVAG AG
  • 13.2.5 ERCHONIA CORPORATION
  • 13.2.6 KONMISON
  • 13.2.7 SKINNOVATION PVT. LTD.
  • 13.2.8 3D AESTHETICS
  • 13.2.9 ZIMMER MEDIZINSYSTEME GMBH
  • 13.2.10 ROHRER AESTHETICS
  • 13.2.11 SKIN AESTHETICS
  • 13.2.12 SHARPLIGHT TECHNOLOGIES INC.
  • 13.2.13 SEBBIN
  • 13.2.14 DEKA M.E.L.A. S.R.L.
  • 13.2.15 INDIBA

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS